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“Here is a biologist examining a culture of nerve cells 
in a small dish. One set of nerve cells examining 
another set of nerve cells. Not quite a trivial scenario.” 
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ABSTRACT 
The wingless/int1 (WNT)/Frizzled (FZD) family of signal transduction pathways is highly 
conserved across species and controls essential physiological functions important for 
embryonic development, stem cell renewal, proliferation, differentiation, and cell polarity. 
Dysregulation of these signaling pathways leads to developmental abnormalities or other 
conditions such as inflammation, cancer, or neurological disorders. In mammals, 19 different 
WNTs can bind to and interact with ten isoforms of FZD in a plethora of combinations. 
These seven transmembrane-spanning receptors are categorized in the Class Frizzled within 
the superfamily of G protein-coupled receptors (GPCRs). Several important co-factors are 
known to aid in the activation of WNT/FZD signaling, such as Disheveled (DVL) or low 
density lipoprotein receptor related protein 5 and 6 (LRP5/6). In addition, interactions of 
FZDs with heterotrimeric G proteins have continuously been reported. Upon ligand binding, 
activation of β-catenin-dependent and/or β-catenin-independent downstream signaling 
pathways takes place. 
The overall aim of this thesis was to shed light on mechanistics of WNT/FZD signaling and 
pharmacology from different angles: In paper I, we investigated the presence and role of 
WNT-5A in human glioblastomas, a WNT important for neurological functions in the central 
nervous system (CNS) and found to be dysregulated in many cancers. In this study, we 
describe the correlative nature of high WNT-5A expression with upregulation of genes 
involved in immunological processes as well as increased microglia infiltration in the tumor 
microenvironment. In paper II and III, we focus on FZD4, a FZD isoform important for 
retinal vascularization. We provide functional evidence for the interaction of FZD4 with 
heterotrimeric Gα12/13, which is independent of DVL and LRP5/6, and show activation of 
downstream signaling events. We further describe a novel signaling route through Norrin-
FZD4-Gα12/13, which exerts an inhibitory effect on the classical Norrin-FZD4-β-catenin 
signaling pathway known to be important in angiogenesis, thus arguing for a concept of 
cross-talk and feedback inhibition from the same FZD isoform, a notion that is as of yet 
completely unappreciated. 
In addition, this thesis tries to point out the current limitations and struggles in the field of 
studying WNT/FZD signaling and the need for further studies identifying crucial links to 
signal specification, which would aid in future drug development targeting this pathway.  
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1 INTRODUCTION 
1.1 THE BEGINNING OF A NEW ERA 
Cellular signaling, or also commonly referred to as signal transduction, is the 
process of cells communicating with their environment or with each other, and 
subsequently responding to external cues being sensed during that process. This 
phenomenon of cells temporally sensing and responding to external stimuli 
basically represents one of or “the” essence(s) of life itself, in its smallest entity. 
Despite many cells having somewhat similar capacities to sense and react to 
surrounding stimuli of all sorts, there can be a great variation in response, 
purpose, and mechanism. Yet, the extent of similarity across species is 
remarkable, especially for example in the eukaryotic kingdom, where 
comparative studies across species can be applied as a tool to advance the field 
of cell signaling in humans.  
The first mentioning of scientific concepts somewhat related to cell signaling 
can be traced back as early as 1855, where French physiologist Claude Bernard 
studied the human pancreas and liver and described a then novel concept of 
“internal secretion”, which would later be known as the endocrine system. 
Despite describing glucose and its precursor in the liver, glycogen, in 
astonishing detail for that time, it wasn’t until early 1900 that two scientists 
named Sir William M. Bayliss and Ernest H. Starling would discover the 
chemical messenger secretin, later named the first “hormone”, while studying 
the process of digestion in dogs (Bayliss et al., 1902). Starling introduced the 
term hormone (derived from the Greek meaning “to arouse or excite”) first in 
1905 as part of his studies on chemical control of physiological functions in the 
body. He insisted that hormones are “…the chemical messengers which 
speeding from cell to cell along the blood stream, may coordinate the activities 
and growth of different parts of the body…” (Starling, 1905). Parallel studies by 
George Oliver and Sir Edward A. Sharpey-Schäfer on suprarenal glands led to 
the early discovery of adrenaline as well as setting the foundations for the field 
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of endocrinology (Oliver et al., 1894). And if one will, those early and primitive 
yet not trivial studies on internal secretions, namely the discovery of secretin as 
well as adrenaline, might have paved the way for a field in science now 
commonly known to us as cell signaling. 
The idea for receptors as we know them today originated in the early 1900’s. 
On one hand, John Langley performed a multitude of experiments on 
sympathetic neuroeffector transmission challenging the then popular notion that 
drugs would act at nerve endings only (Langley 1901, 1905). On the other hand 
and around the same time as Langley, Paul Ehrlich laid out some of the basics 
for a receptor concept in his studies on toxins and his “receptive side chain 
theory”, from which he would later derive the term “receptor”, comparing it in 
the context of cellular toxins to a “lock and a key” (Ehrlich, 1956). Ehrlich was 
awarded the Nobel Prize for Physiology or Medicine in 1908 together with Ilya 
Metchnikoff for their contributions to the field of immunology (""The Nobel 
Prize in Physiology or Medicine 1908"," 1908).  
The earliest structural models for G protein-coupled receptors (GPCRs) were 
derived from correlations with a bacterial integral membrane protein, the 
bacteriorhodopsin, for which structures had been resolved almost a century after 
Ehrlich’s initial receptor theory (Grigorieff et al., 1996; Kimura et al., 1997; 
Pebay-Peyroula et al., 1997). Only several years later, the first crystal structure 
of a mammalian GPCR was solved with experiments on the bovine rhodopsin 
receptor (Palczewski et al., 2000). In 2007, the first crystal structure of a human 
GPCR, the β2-adrenergic receptor, followed (Rasmussen et al., 2007) and a 
high-resolution model was constructed (Cherezov et al., 2007; Rosenbaum et 
al., 2007). Since then, close to 800 members of the superfamily of GPCRs have 
been identified (Bjarnadottir et al., 2006), and solving the crystal structure of 
each and every one of them remains a major challenge in the field, with many 
orphan GPCRs not even having ligands identified as of yet.  
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1.2 WNT/FRIZZLED SIGNALING  
1.2.1 A brief history of WNTs and Class Frizzled receptors 
The definition of the WNT family of lipoglycoproteins was based on two 
historical findings several decades ago. On one hand, Varmus and Nusse, who 
had worked on identifying oncogenes in mice causing mammary tumors, 
identified in 1982 a new proto-oncogene with the ability to transform mouse 
mammary cells, which they termed int-1 (derived from “integration” of the 
MMTV virus into the genome of mouse mammary carcinomas) (Nusse et al., 
1982). Slightly earlier, studies on embryonic development in fruit flies 
(Drosophila melanogaster) led to the discovery of a gene causing deformation 
and loss of wing tissue when mutated, and was thus termed wingless (Wg) 
(Sharma, 1973). It took several more years for scientist to realize that the mouse 
int-1 gene and the drosophila wingless gene were homologues (Cabrera et al., 
1987; Rijsewijk et al., 1987). Once further int-1-related genes were discovered 
but in different manners, the scientific community agreed to rename these 
genes, which showed prospects of becoming a substantial new family of 
mammalian genes, into Wnt, a mnemonic for int and Wg (Nusse et al., 1991). 
The discovery of the WNT family indeed opened up an immense field of 
research enabling insights into the details of molecular signaling in 
development, physiology, as well as diseases and many new and promising 
pharmacological targets (reviewed extensively in (Klaus et al., 2008)). 
FZDs, the receptors for WNTs, were identified around the same time as their 
ligands but independently of them, precisely through a screen for mutations in 
Drosophila polarity genes (Bridges et al., 1944). The fruit fly provides an 
excellent system for studying embryonic development, and in particular cell and 
tissue polarity. And so, the frizzled pathway soon became a popular subject for 
studying planar polarity in different body regions of the fruit fly, such as the 
wings, the eyes, as well as sensory bristles (Gubb et al., 1982; Vinson et al., 
1987; Wong et al., 1993).  
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The connection, that WNTs are the ligands for FZDs, was made several years 
after these proteins were first discovered. It was shown that in Drosophila, 
mutations in frizzled and disheveled, later to be identified as a crucial scaffold 
protein in the WNT/FZD pathway, caused a similar phenotype in vivo 
(Krasnow et al., 1995). Shortly after, more evidence was gathered strengthening 
the idea and finally confirming that FZDs function as receptors for WNTs 
(Bhanot et al., 1996; Yanshu Wang et al., 1996). 
1.2.2 WNTs and Norrin 
WNTs in mammals constitute a group of 19 different lipoglycoproteins, all of 
which are by now commercially available as recombinant proteins (R&D, 
USA). Purification of WNTs has been a challenge ever since it was first 
achieved due to its lipid modifications (Willert et al., 2003). WNTs are purified 
by harvesting conditioned media of WNT-overexpressing mammalian cells 
followed by fractionation, immobilization, and subsequent purification (Schulte 
et al., 2005; Willert et al., 2003). Despite many modifications to this process, it 
remains a challenge to obtain intact, lipophilic and biologically active WNT 
protein and in addition, the use of conditioned media introduces a range of 
additional and sometimes unknown factors into experimental setups. 
Norrin was discovered to be an atypical, FZD4-selective ligand after studies in 
mice with mutations in FZD4 showed compelling similarities to mice displaying 
Norrie disease, an eye disorder caused by defective retinal vascular 
development (Berger et al., 1996). Earliest report on the Norrin-FZD4 
interaction showed that together with the co-receptor LRP5/6, Norrin and FZD4 
activate WNT/-catenin signaling in mammalian cells (Xu et al., 2004). Besides 
its angiogenic properties important for vascularization of the eye and the inner 
ear (Luhmann et al., 2005a; Ohlmann et al., 2005; Rehm et al., 2002; Richter et 
al., 1998), Norrin has also been shown to exert neuroprotective properties via 
the WNT/-catenin signaling pathway (Seitz et al., 2010).  In addition, loss of 
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Norrin in mice affects reproduction through loss of vascularization and 
malformation of the endometrium (Luhmann et al., 2005b).   
1.2.3 Class Frizzled receptors 
FZDs share typical structural features with GPCRs, most commonly the well-
known 7-transmembrane-spanning structure, but also lack substantial other core 
features like important conserved structural domains, and have thus been 
categorized per the International Union of Basic and Clinical Pharmacology 
(IUPHAR) classification as class Frizzled receptors within the GPCR receptor 
superfamily. This class contains 10 mammalian FZDs and one Smoothened 
(SMO) receptor (Foord et al., 2005). Amongst themselves, FZDs show various 
degrees of sequence homologies and several clusters can be differentiated: 
FZD1, 2, 7 (75%), FZD5, 8 (70%), FZD4, 9, 10 and FZD3, 6 (50%) (Fredriksson et al., 
2003). Besides the 7-TM structure, FZDs contain an extracellular N-terminus 
with a signal sequence followed by a cysteine-rich domain (CRD), the putative 
site for ligand recognition and binding of some co-receptors (Xu et al., 1998). 
The transmembrane core of the receptor consists of 3 intracellular and 3 
extracellular loops as well as an intracellular C-terminus of various lengths. The 
C-terminus is characterized by a conserved KTxxxW domain for binding the 
PDZ domain of the scaffold protein Disheveled (DVL) (Umbhauer et al., 2000), 
several potential contact sites for heterotrimeric G proteins, as well as a terminal 
domain for binding of other PDZ-domain proteins (Schulte et al., 2007). In 
addition, a wide range of different phosphorylation sites has been identified for 
most FZDs, most of them though based on in silico analyses of conserved 
structural features (Schulte, 2010), rather than in vivo/vitro data (Yanfeng et al., 
2006).  
1.2.3.1 Disheveled 
One major interacting partner of FZDs is the cytoplasmic scaffold protein DVL, 
of which three variants are known in humans (DVL1, 2 and 3) (Gao et al., 
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2010). The DVL protein is characterized by three major domains: an N-terminal 
DIX domain, a central PDZ domain, and a C-terminal DEP domain (Li et al., 
1999; Wong et al., 2000). DVL acts downstream of FZD as a scaffold protein 
and various reports suggest that DVL activates specific signaling pathways via 
distinct domains. For instance, the DIX domain is crucial for -catenin-
dependent signaling (Penton et al., 2002; Yanagawa et al., 1995), the PDZ 
domain for -catenin-dependent  as well as for -catenin-independent signaling 
(Ciani et al., 2007; Habas et al., 2003; Krylova et al., 2000; Penton et al., 2002), 
while the DEP domain is essential mainly in -catenin-independent signaling 
e.g. in the functional regulation of small GTPases like Rho by activating Rac 
and JNK (Axelrod et al., 1998; Habas et al., 2003; Rosso et al., 2005). 
Moreover, the DEP domain together with a classical C-terminal motif were 
shown to be required for FZD binding and WNT-induced β-catenin activation 
necessary in cultured cells and Xenopus embryos (Tauriello et al., 2012). In 
addition, DVL is known to get phosphorylated in response to WNT and FZD 
binding, both in vivo and in vitro, a process reportedly depending on a 
functional DEP domain (Bernatik et al., 2011; Bryja et al., 2007b; Rothbächer 
et al., 1995; Tada et al., 2000). Despite much emphasis on the role of DVL in 
WNT/FZD signaling, detailed mechanistic information on the structural or 
functional interaction of DVL with FZDs, and in combination with or without G 
proteins, remains unknown. The fact that the interface for G protein-FZD 
interaction (Wess, 1998) topologically overlaps considerably with the region of 
FZD-DVL interaction (Tauriello et al., 2012; Wong et al., 2000) creates further 
confusion in the search for a model describing this multi-protein complex. 
Concerning the FZD/Ca2+ pathway, it is not certain whether DVL acts upstream 
(Sheldahl et al., 2003) or downstream (Katanaev et al., 2005) of heterotrimeric 
G proteins. One likely model explaining the G protein-DVL relationship is that 
of dividing the FZD-transduced signaling simultaneously into fast G protein-
dependent (Ma et al., 2006) and slow DVL-dependent signaling (Bryja et al., 
2007a; González-Sancho et al., 2004; Liu et al., 2005). Another, maybe more 
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unconventional theory is that of FZD indirectly activating G proteins via DVL, 
similar to the proposed link between FZD4 and β-arrestin (Chen et al., 2003). 
Such a detour could explain many of the experimental difficulties we and others 
are facing in studying FZD-G protein interaction (see also Materials & Methods 
section).  
1.2.3.2 FZD co-receptors 
Several different co-receptors are known to interact with FZDs in various ways, 
among them are e.g. low density lipoprotein receptor-related protein (LRP) 5/6, 
related to receptor tyrosine kinase (RYK), and receptor tyrosine kinase (ROR) 
1/2 (discussed in detail in (Schulte, 2010)). Out of these, LRP5 and LRP6 have 
been studied the most in regards to WNT/FZD signaling. LRP5/6 are 
transmembrane proteins with a single membrane spanning domain and are well 
known to hold essential roles in the signal transduction of β-catenin-dependent 
WNT signaling (Pinson et al., 2000). Numerous reports have confirmed that 
several different WNTs can bind to the N-terminus of LRP5/6 to initiate 
signaling by further binding to FZDs and thus activating downstream signaling 
events (He et al., 2004; Itasaki et al., 2003; Liu et al., 2003; Mao et al., 2001).  
1.2.4 WNT/FZD signaling pathways 
Historically, WNT/FZD signaling has been divided into two main pathways 
depending on the involvement of -catenin (formally termed -catenin-
dependent or -catenin-independent signaling pathways), a versatile 
transcriptional regulator. With increasing knowledge of the field, relying on -
catenin only as a default player in the pathway has proven too simple in many 
instances, and thus most commonly the various pathways involving WNT/FZD 
are being referred to by their main components involved.     
The -catenin-dependent signaling pathway has been extensively studied since 
its discovery in the 1990’s with the help of various robust assays such as 
transformation of C75MG cells (Wong et al., 1994), transcriptional regulation 
1   Introduction 
 8 
of target genes (e.g. TOPFlash assay (activation of the luciferase T-cell specific 
transcription factor/lymphoid enhancer factor (TCF/LEF)-driven reporter 
(Molenaar et al., 1996; Van de Wetering et al., 1996))), -catenin stabilization 
assayed by immunoblotting or immunocytochemistry, phosphorylation of 
upstream effector proteins, or dorsal body axis formation in Xenopus embryos 
(Heasman et al., 1994; Schneider et al., 1996).  
In the absence of WNTs, cytosolic -catenin levels are kept low by continuous 
phosphorylation through casein-kinase 1 (CK1) and glycogen synthase kinase 3 
(GSK3), which form part of a multimeric destruction complex besides other 
proteins like axin and adenomatous polyposis coli (APC) (Klaus et al., 2008; 
MacDonald et al., 2009). Upon the presence of ligands, WNTs induce 
interaction of FZDs and the co-receptor LRP5/6 by direct interaction with both. 
This causes CK1 and GSK3 to be released from the destruction complex and 
phosphorylate LRP5/6. Subsequently, further redistribution of proteins leads to 
a stabilization of -catenin in the cytoplasm and translocation to the nucleus, 
where it binds TCF/LEF transcription factor family proteins to induce 
transcription of target genes related to e.g. cell proliferation, growth, and other 
vital cellular functions (Figure 1 top left two cartoons) (reviewed in detail in 
(Schulte, 2010) as well as http://wnt.stanford.edu).   
Besides signaling to -catenin, WNT/FZD signaling is involved in many other 
cellular pathways involving various proteins. Amongst the best described are: 
WNT/RAC, WNT/RHO, WNT/Ca2+, FZD/PCP, WNT/cAMP, and WNT/ROR 
(Figure 1) (compare (Schulte, 2010; Semenov et al., 2007). Historically, with 
limited knowledge about the ever-growing complexity we have of WNT/FZD 
signaling today, it came easy to strictly divide the different pathways based on 
the involvement of -catenin or major other players mentioned above. 
Technical advancements in biomedical sciences such as low-cost RNA/DNA 
sequencing (reviewed in (Goodwin et al., 2016)) or fast and relatively 
inexpensive gene editing tools such as CRISPR/Cas9 lead to an explosion of 
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discoveries in fields such as cell and molecular biology (Cong et al., 2013; 
Jinek et al., 2012). More and more evidence indicates that some of these 
previously strictly separated WNT/FZD pathways might after all converge, 
overlap or interact with each other at various points in a downstream signaling 
cascade (Halleskog et al., 2013; Park et al., 2015) (paper III).  
 
Figure 1. Schematic overview of WNT/FZD signaling. Individual cartoons depicting 
WNT/-catenin, WNT/RAC and RHO, WNT/Ca2+, PCP, WNT/cAMP, and WNT/ROR 
signaling pathways. Image from Schulte et al. 2010.  
1.3 GPCR SIGNALING  
The family of GPCRs comprises close to 800 members in the human genome 
and constitutes the largest, and at the same time, most diverse group of 
membrane receptors in eukaryotes (Bjarnadottir et al., 2006). GPCRs share 
common structural features including an extracellular N-terminus, a 
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hydrophobic 7-transmembrane-spanning core (7-TM), and an intracellular C-
terminus. These cell surface receptors regulate a vast pool of cellular functions, 
and it comes as no surprise that roughly 30-40% of all approved drugs 
worldwide target members of this class of proteins (yet only roughly 50 GPCRs 
make up this vast number of drugs) (Hopkins et al., 2002; Wise et al., 2002). 
Interestingly enough, there are still about 120 members for which specific 
ligands have yet to be identified (Chung et al., 2008). As the name implies, 
GPCRs relay signals into the cell by means of heterotrimeric G proteins. 
Binding of an extracellular ligand to a GPCR induces a conformational change 
and causes subsequent heterotrimeric G protein recruitment to the receptor, 
accompanied by an exchange of GDP to GTP at the alpha subunit of the G 
protein, indicating the/accompanied by the activation of the G protein 
(Alexander et al., 2015) (for a comprehensive and up-to-date review see (Ghosh 
et al., 2015)).  
A longstanding and still mostly valid model for the functional interaction of 
ligand, GPCR and heterotrimeric G proteins is the so-called “ternary complex 
model”, explaining the reversible interaction between a ligand, receptor, and G 
proteins (De Lean et al., 1980). Two main models have emerged over time and 
based on evidence, aiming at explaining the dynamics of the receptor-G protein 
interaction. The first model is called “collision coupling”, in which ligand-
bound , and thus active, receptors and G proteins randomly collide and couple 
transiently and reversibly, resulting in the activation of the G protein (Gilman, 
1987; Hein et al., 2009; Leff, 1995; Tolkovsky et al., 1978; Tolkovsky et al., 
1981). This model confirms the original GPCR-G protein model hypothesizing 
that agonist binding is required for a GPCR-G protein physical interaction and 
activation to take place. Moreover, this model is also in agreement to some 
degree with the ternary complex model, where the agonist–receptor–G protein 
complex is stable without the presence of guanine nucleotides, and only once 
GTP exchange occurs the complex dissociates. The second model postulates 
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that GPCRs and G proteins can exist in a “pre-coupled” or “pre-assembly” state 
before agonist binding (Gales et al., 2006; Hein et al., 2009; Neubig, 1994; 
Rebois et al., 2003). Here, agonist binding initiates receptor activation, leading 
to conformational changes of the pre-assembled receptor-G protein complex 
and resulting in G protein. This model provides ideas for potentially 
accelerating the rate of G protein activation by eliminating the rate-limiting step 
of the collision coupling model, the random collision of receptor and G protein. 
1.3.1 G proteins and FDZs 
Soon after FZDs were first discovered, analyses of their primary amino acid 
sequence quickly led to the conclusion that they were, at least structurally, 
related to GPCRs (Barnes et al., 1998). Since then, an overwhelming amount of 
evidence in various organisms has provided compelling arguments for a FZD/G 
protein liaison (Arthofer et al., 2016; Egger-Adam et al., 2008; Kilander et al., 
2014a; Kilander et al., 2011a; Kilander et al., 2014b; Riobo et al., 2007; 
Slusarski et al., 1997a; Slusarski et al., 1997b; Wu et al., 2000). Despite all the 
evidence of FZDs acting as “real” GPCRs, it cannot be denied that FZDs, being 
able to evidently signal without the involvement of heterotrimeric G proteins, 
are atypical GPCRs (Egger-Adam et al., 2008; Schulte et al., 2007). Recent 
studies from our group have shed new light on the involvement of DVL in 
regards to FZD-G protein signaling. On one hand, we observed that the 
interaction and signaling capacity of FZD6 with Gαi1 and Gαq depend on defined 
intracellular levels of DVL (Kilander et al., 2014b). In contrast, the inactive-
state complex between FZD4 and Gα12/13 did not depend on DVL levels or its 
general presence at all (Arthofer et al., 2016), raising doubts whether a uniform 
FZD-G-protein-DVL complex model might even exist, as compared to a unique 
model for each FZD isoform-specific signaling route. Similarly, we recently 
generated data showing a FZD4-Gα12/13 inactive state complex assembly, which 
can be dissociated upon Norrin stimulation, irrespectively of pretreatment with 
Dickkopf-1 (DKK-1), an inhibitor of LRP5/6 binding to FZD, or co-
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transfection of a dominant-negative phosphorylation-dead LRP6 mutant (Wolf 
et al., 2008). Phosphorylation of LRP5/6 by either GSK3 (Zeng et al., 2008; 
Zeng et al., 2005) or CK1 (Davidson et al., 2005; Zeng et al., 2005) is 
associated with the accumulation of proteins such as LRP6, Axin, and DVL, 
and viewed as a starting step for the formation of a LRP6 signalosome, causing 
-catenin accumulation in the cytoplasm and activation of downstream WNT 
signaling.  
One of the ultimate quests in cellular biology and signaling is to precisely 
define cellular circumstances leading to and executing specific signaling events. 
However, a multitude of factors such as type of ligands, co-factors, as well as 
co-receptors present, or cell type, cell compartment, and stage of development, 
or other yet unknown elements can all play a role in any given signaling event. 
Yet, in regards to WNT/FZD signaling, it becomes more and more obvious that 
there might be certain elements, which may dictate FZD isoforms to signal 
either towards heterotrimeric G proteins or signaling routes involving e.g. LRP6 
and DVL.  
1.4 GLIOMA MICROENVIRONMENT 
Malignant gliomas are amongst the deadliest types of cancer and represent over 
80% of malignant brain tumors. Glioblastoma is the most common malignant 
glioma subtype, accounting for almost 45% of all gliomas. The median survival 
time for patients suffering from glioblastoma is less than 15 months, with a 5-
year relative survival of under 5% (Ostrom et al., 2014). The standard treatment 
regimen for malignant gliomas typically involves surgical resection followed by 
chemotherapy and/or radiation therapy (Stupp et al., 2007). The World Health 
Organization (WHO) has established a grading system, grade I-IV, for gliomas 
based on malignant behavior. The most commonly occurring histologic types of 
gliomas in adults, named after their cellular origin, include astrocytoma, 
oligodendroglioma, and oligoastrocytoma. Glioblastoma, also sometimes 
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referred to as glioblastoma multiforme (GBM) are classified as grade IV 
astrocytomas (Kleihues et al., 1993). 
Gliomas are histologically very heterogeneous, which has shown to be one of 
the major obstacles for successful therapeutic intervention (Holland, 2000). It is 
clear today that the tumor microenvironment of malignant gliomas does not 
only significantly contribute to tumor initiation and progression, but also 
heavily to tumor metastasis (Hu et al., 2008).  The complex glioma 
microenvironment is typically composed of neurons, astrocytes, microglia, 
fibroblasts, pericytes, and endothelial cells (Charles et al., 2011). Nonmalignant 
astrocytes are specialized glial cells in the brain providing structural support 
amongst other essential functions and have long been suspected to play a role in 
the progression of malignant brain tumors. Once attracted to the tumor, these 
tumor-associated astrocytes (TAAs) can become activated by various factors in 
the tumor microenvironment and display distinct epithelial-to-mesenchymal 
(EMT) transition and enhanced migration and invasion activity, making them 
one potential target for therapy (Charles et al., 2011; Lu et al., 2016; Seike et 
al., 2011; Shabtay-Orbach et al., 2015). In addition to astrocytes, microglia, the 
immunocompetent macrophages of the central nervous system (CNS), hold 
another important role in the pathobiology of malignant glioma. As the resident 
macrophages of the CNS, microglia have been shown to maintain homeostasis 
and respond to damages of the CNS with a range of reactions: change of 
morphology (“active” microglia) or motility, or changes in gene expression and 
pro-inflammatory cytokine release (Charles et al., 2011; Eggen et al., 2013; 
Gertig et al., 2014; Hanisch et al., 2007; Kettenmann et al., 2011). Microglia 
can be stimulated by various signaling molecules such as neurotransmitters, 
growth factors, or morphogens (Hanisch, 2002; Pocock et al., 2007), which 
emphasizes the importance of ongoing communication between microglia and 
e.g. astrocytes, neurons, or oligodendrocytes in determining microglia fate and 
functions in the CNS. Microglia activation is known to be important in 
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developmental processes in the brain like synaptic remodeling, but also 
accompanies several neurological pathologies such as infections, brain tumors, 
neuropathic pain, or neurodegenerative diseases (Graeber, 2010; Halleskog et 
al., 2011). Considering the enormous importance of both -catenin-dependent 
and -catenin-independent WNT signaling in neuronal development and 
homeostasis (De Ferrari et al., 2006; Inestrosa et al., 2010) (Henríquez et al., 
2012), it comes as no surprise that WNT signaling can also have an effect on 
the microglia response in the brain (Halleskog et al., 2011; Kilander et al., 
2011b; Pukrop et al., 2010).  
Despite the role of microglia as the healthy brain’s immune defense, various 
reports have shown that in glioma patients, microglia might have the potential 
to do the contrary, to promote tumor growth and migration (Bettinger et al., 
2002; Markovic et al., 2005; Zhai et al., 2011). This is especially astonishing in 
the light of scientific evidence describing microglia as the antigen presenters of 
the CNS due to their expression of major histocompatibility (MHC) class II 
molecules (Proescholdt et al., 2001; Tran et al., 1998). While it seems that these 
cells are perfectly equipped to function as antigen presenting cells, functional 
antigen presentation to helper or cytotoxic T cells does not occur, leaving room 
for speculation as to what their real function is in malignant gliomas. One study 
explains this failed antigen presentation by pointing to a lack of expression of 
costimulatory factors and thus downregulation of T cell activation (Flügel et al., 
1999).  
1.4.1 Malignant gliomas and WNT signaling 
Limited evidence is available thus far on the exact role WNTs play in malignant 
glioma pathophysiology. Some reports give importance to β-catenin-dependent 
signaling since high DVL2 levels in cultured and patient-derived glioma cells 
promote proliferation and differentiation, and likewise, cells with depleted 
DVL2 levels do not form tumors after intracranial injection into 
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immunodeficient mice (Pulvirenti et al., 2011). Furthermore, inhibition of 
GSK3β prevents neurosphere formation in ex vivo GBM cultures (Korur et al., 
2009). Regarding the importance of specific WNTs in glioma pathophysiology, 
WNT-5A, previously shown to have both tumor suppressive and oncogenic 
effects in cancer (McDonald et al., 2009), has drawn the most attention thus far. 
First indications for a role of WNT-5A in malignant glioma came when several 
groups reported that Wnt5A levels in human GBM were higher compared to 
normal brain tissue and low-grade astrocytoma (Kamino et al., 2011; Pu et al., 
2009; Yu et al., 2007) (Paper I). In addition, complementary in vitro studies in 
one of the recently-turned-infamous GBM cell lines U87MG (Allen et al., 
2016) showed increased proliferation upon WNT-5A overexpression. Further 
studies complemented these initial findings confirming WNT-5A to be essential 
for glioma cell proliferation and invasion (Kamino et al., 2011; Pu et al., 2009; 
Pulvirenti et al., 2011). Despite several reports pinpointing WNT-5A to GBM 
progression, more research will need to be done to understand underlying 
mechanistic details. 
1.4.2 WNT/G protein signaling and microglia 
The idea of WNT signaling to heterotrimeric G proteins in microglia is rather 
young and was first formed when our group previously published findings that 
recombinant WNT stimulation activates heterotrimeric G proteins in primary 
mouse microglia cells and N13 microglia cells (Halleskog et al., 2012; Kilander 
et al., 2011a). In one study, they showed that recombinant WNT-5A provoked a 
proliferative response in the mouse microglia-like cell line N13, which was 
sensitive to PTX. In addition, activation of Gαi/o proteins in N13 and primary 
microglia by WNT-5A was corroborated using the GTPγS binding (Kilander et 
al., 2011a). In a further study, our group investigated intracellular transduction 
pathways in primary mouse microglia cells and revealed that WNT-5A 
activates heterotrimeric Gαi/o proteins to reduce cyclic AMP (cAMP) levels and 
to activate a Gαi/o protein/phospholipase C/calcium-dependent protein 
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kinase/ERK1/2 axis. In addition, they showed that ERK1/2 signaling induced 
by WNT-5A causes distinct aspects of the pro-inflammatory transformation 
seen in microglia, including proliferation, expression of matrix metalloprotease 
9/13, invasion (Halleskog et al., 2012).  
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2 AIMS 
This thesis aims to understand if, how, and where FZDs function as GPCRs and 
more precisely, to gain insight into mechanistic details of FZDs acting as 
GPCRs relevant for pathological manifestations. Specifically, our aims were:  
 To investigate the presence of WNT-5A in glioblastoma samples and to 
decipher the role of WNT-5A within the glioma tumor 
microenvironment with a focus on tumor-associated microglia (Paper I). 
 To explore G protein coupling and potential G protein specificity of 
FZD4 (Paper II + III). 
 To verify signaling activation through FZD4 and Gα12/13 induced by 
WNTs and Norrin (Paper II + III). 
 To investigate Norrin-induced signaling via β-catenin-independent but 
G protein-dependent pathways (Paper III). 
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3 MATERIALS & METHODS 
Most of the techniques used in the studies for this thesis are widely considered 
standard methods. For a detailed description of the procedures please see the 
Materials & Methods section in each individual publication. In this section, I 
will mainly describe the shortcomings of some or total lack of assays to study 
various aspects of WNT/FZD signaling. 
Table 1. List of methods used in the publications comprising this thesis. 
Method Paper 
Cell culture II, III 
Cell transfection II, III 
Molecular cloning  II, III 
WNT/Norrin stimulation or inhibitor treatment II, III 
SDS-PAGE/Immunoblotting II, III 
Immunohistochemistry I 
Immunocytochemistry II, III 
Luciferase reporter assay II, III 
p115RhoGEF recruitment assay II 
Fluorescent/Confocal microscopy/Live cell imaging I-III 
Double color fluorescence recovery after photobleaching 
(FRAP) 
II 
Förster resonance energy transfer–Photoacceptor bleaching 
(FRET) 
II 
Bioinformatic analyses: TCGA GBM dataset analysis, MiMi 
interactome network analysis, MCODE analysis, GO 
analysis, GSEA analysis, KEGG pathway analysis, co-
occurrence analysis 
I 
Dynamic mass redistribution  II 
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3.1 METHODOLOGICAL CONSIDERATIONS 
3.1.1 Cell systems to study WNT/FZD signaling 
One major challenged we face when studying WNT/FZD signaling on a 
molecular level is the choice of an appropriate cell model. Many commonly 
used and commercially available cell lines such as HEK293, HeLa, HEPG2, or 
others show expression of most of the 10 FZD isoforms (unpublished data and 
(Halleskog et al., 2012). Many of the 19 WNTs, which are all commercially 
available but often have doubtful purity and activity, have been shown to bind 
to, interact with, and act on more than one FZD isoform, creating numerous 
possible WNT/FZD interaction pairs (for an overview of reported WNT/FZD 
interactions see Figure 2 in (Dijksterhuis et al., 2014)).  
Our laboratory recently published work on a 32D cell-based system engineered 
to overexpress FZD2, FZD4, or FZD5, which allows for systematic assessment 
of functional selectivity of purified WNTs for individual FZDs. This is possible 
because 32D cells show low or undetectable endogenous mRNA levels for the 
ten FZD isoforms (Dijksterhuis et al., 2015b). Establishing FZD isoform-
selective cell lines provides a substantial advantage for selectively targeting 
individual FZDs. On the other hand, using cells that endogenously express 
single FZD isoforms at probably sub-physiologically relevant levels could hint 
that those cells might not have all the necessary additional machinery for 
functional WNT/FZD signaling and thus are not ideal for studying 
physiological aspects of the WNT/FZD signaling pathway.  
Equally challenging is the fact that almost all cells naturally express and secrete 
WNT proteins in an autocrine and paracrine fashion, which has been known 
across species for quite some time (Lawrence et al., 1996; Nolo et al., 2000; 
Zecca et al., 1996). The development of a class of pharmacological small-
molecule WNT inhibitors called porcupine inhibitors, named after their 
inhibitory function of the membrane bound O-acyltransferase PORCN, which is 
required for WNT palmitoylation, secretion, and biologic activity (Kurayoshi et 
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al., 2007; Najdi et al., 2012; Proffitt et al., 2012; Takada et al., 2006). Currently, 
there are several inhibitors on the market available to use for biomedical 
research, which are C59 (Proffitt et al., 2013), LGK974 (Liu et al., 2013), ETC-
159 (Madan et al., 2016), as well as inhibitors of WNT production (IWP)-2, -
L6, -12 (Chen et al., 2009), some of which are currently also tested in clinical 
trials to inhibit aberrant WNT signaling (LGK974: NCT01351103, 
NCT02649530, NCT02278133; ETC-159: NCT02521844). 
Another way to selectively study one FZD isoform only is by creating stable 
cell lines overexpressing a fluorescently-tagged or epitope-tagged FZD 
(unpublished data). This way, the FZD in question is stable (over)expressed and 
easily recognized by fluorescent microscopy or immunoblotting, and any 
pharmacological intervention such as ligand stimulation or inhibition is likely 
acting on the overexpressed FZD isoform and not on lower expressed 
endogenous FZDs. Nevertheless, said endogenous FZD expression or 
overexpression artefacts due to high exogenous protein levels in the cell can 
skew experiments performed with such cells. Therefore, any meaningful 
conclusions drawn with such overexpression systems need careful validation by 
employing several different experimental assays together to individually reach 
the same conclusions.   
3.1.2 FZD and G protein activation assays 
As mentioned before, even though FZDs are classified and widely 
acknowledged throughout the scientific community to be GPCRs, the main 
feature of GPCRs, which is to bind to and activate heterotrimeric G proteins, 
presents literally as “the struggle of a lifetime” for many researchers in the 
WNT field. Because of a wide array of potential WNT/FZD interactions and a 
lack of physiological cell models expressing a single FZD isoform only, 
studying G protein interaction and activation for individual FZDs has proven 
challenging. Radiometric methods such as radioligand binding or GTPγS 
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measurement were the first to be developed for GPCR activation, but are 
difficult to perform because they require advanced laboratory setups and again, 
endogenous FZD levels might skew any results obtained. Classical non-
radiometric assays such as cAMP or calcium measurements, however, can only 
be used for selected Gα subtypes. For example, calcium measurement is 
selective for Gαq-coupled receptors whereas cAMP is selective only for Gαs and 
Gαi/o-coupled GPCR (see Table 2). Therefore, these assays require well-
characterized signaling pathways, a fact which is near impossible in cell lines 
with more than one FZD expressed. In addition, several G protein activation 
assays known to work with a broad range of classical GPCRs turned out to not 
be suitable for studying FZDs (unpublished data), in many cases for unknown 
reasons, yet reinforcing the notion that class Frizzled receptors differ to varying 
degrees from classical GPCRs in function as well as G protein specificity and 
selectivity (Schulte, 2010).  
Table 2. Summary of conventional G-protein dependent assays for mammalian cell systems 
suitable to study FZD-G-protein interaction with a focus on G alpha subunits. Additional 
information on G protein-specific pharmacological agents including references: PTX inhibits 
Gi/o/t activation by catalyzing ADP-ribosylation of said G proteins (Barbieri et al., 1988; 
Bokoch et al., 1983; Casey et al., 1989); YM-254890 inhibits Gq by inhibiting the GDP to 
GTP exchange (Taniguchi et al., 2003); UBO-QIC inhibits Gq by preventing the activation 
of Gq (Takasaki et al., 2004); GP-2A is a competitive Gq inhibitor (Tanski et al., 2004); Y-
27632 inhibits G12/13 by specifically blocking RhoA (Ishizaki et al., 2000); Melittin inhibits 
Gs and activates Gi (Fukushima et al., 1998; Raghuraman et al., 2007); The suramin 
analogue NF023 inhibits Gi/o (Freissmuth et al., 1996); Green font indicates activation of the 
G subunit as opposed to black font indicating inhibition.  
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G 
protein 
family 
 subunit Main signal 
transduction 
route 
Commonly 
available 
assays 
G protein-specific 
pharmacological 
intervention 
Evidence for G 
protein-FZD 
interaction 
Gi family 
Gi/o i, o Inhibition of 
adenylyl cyclase 
( cAMP) 
cAMP assay 
Ca2+  
GTPγS binding 
SRE reporter 
Pertussis toxin 
(PTX) 
Suramin analogue 
NF023 
Melittin (Gi) 
rFZD2 (Gi or Go) - 
(Slusarski et al., 1997a) 
FZD? (Go) – (Liu et al., 
2005) 
hFZD1 (Go) – 
(Katanaev et al., 2009) 
hFZD1 (Gi) – (Koval et 
al., 2011) 
hFZD6 (Gi) –(Kilander 
et al., 2014b) 
Gt t 
(Transducin) 
Activation of 
phosphodiesterase 
(PDE) 
GTPγS binding 
Time-resolved 
fluorescence 
spectroscopy 
 rFZD6 (Gt) - (Ahumada 
et al., 2002) 
Ggust gust 
(Gustducin) 
Activation of PDE Ca2+  
cAMP  
  
Gz z Inhibition of 
adenylyl cyclase 
( cAMP) 
cAMP    
Gs family 
Gs s Activation of 
adenylyl cyclase 
( cAMP) 
cAMP  
FZD Co-IP 
CRE reporter  
Melittin  
Cholera toxin (Gs) 
FZD7 – (von Maltzahn et 
al., 2011) 
Golf olf Activation of 
adenylyl cyclase 
( cAMP) 
cAMP  
CRE reporter  
  
Gq family 
Gq q, 11, 14, 
15, 16 
Activation of 
phospholipase C 
( IP3 and Ca2+) 
Ca2+  
IP3  
NFAT-RE 
reporter  
YM-254890 (Gq) 
FR900359/UBO-
QIC (Gq) 
GP-2A (Gq) 
rFZD2 (Gq) – (Ma et al., 
2006) 
hFZD6 (Gq) – (Kilander 
et al., 2014b) 
G12/13 family 
G12/13 12, 13 Activation of the 
Rho family of 
GTPases 
Ectodomain 
shedding of TGF 
p115-RhoGEF 
recruitment 
SRF-RE reporter  
Yap/Taz reporter  
TGF shedding  
C3 toxin (blocks 
Rho) 
FZD1 (G12/13) – (Park et 
al., 2015) 
hFZD4 (G12/13) – 
(Arthofer et al., 2016) 
hFZD10 (G13) – (Hot et 
al., 2017)  
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4 RESULTS & DISCUSSION 
Ever since the discovery of FZDs and the subsequent notion that this class of 
receptors shares key structural features with the superfamily of GPCRs, their 
potential to function as GPCRs has been disputed. Based on overwhelming 
structural and functional evidence in various species over the past decades, 
FZDs were grouped into their own class F among the GPCR family by the 
IUPHAR and The British Pharmacological Society in “The Guide to 
Pharmacology” (Alexander et al., 2015; Foord et al., 2005; Schulte, 2010). 
Despite a growing pool of evidence showing direct interactions of FZDs and 
heterotrimeric G proteins (see Table 2 and recently reviewed in (Dijksterhuis et 
al., 2014)), we and many other groups studying WNT/FZD signaling pathways 
remain largely in the dark when it comes to describing details of structural, 
functional, and physiological properties of WNTs, FZDs, G proteins and other 
involved components of this signaling path/of WNT/FZD signaling 
mechanistics.  
4.1 WNT-5A IN HUMAN MALIGNANT GLIOMA  
In order to answer the ever-present questions, if, how, and where FZDs function 
as GPCRs, we had previously been studying WNT signaling in microglia cells. 
By using immortalized N13 and primary mouse microglia cells we could show 
that microglia are sensitive to ectopic WNT-3A and WNT-5A stimulation by 
increasing their proliferative potential, which for most part could be blocked by 
the Gαi/o inhibitor PTX (Halleskog et al., 2012; Halleskog et al., 2013; Kilander 
et al., 2011a; Kilander et al., 2011b). WNT-5A stimulation of microglia also 
mirrored increased invasive potential and caused upregulation of inflammatory 
markers by these cells (Halleskog et al., 2012). Since microglia represent the 
immunocompetent cells of the brain and CNS and play an important role in 
brain inflammatory processes, we decided to turn to brain tumors to investigate 
the role of WNT signaling and WNT-5A further.   
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4.1.1 High levels of WNT-5A in human glioma correlate with increased 
presence of tumor-associated microglia  
Based on several reports showing upregulation of WNT-5A in human glioma 
and GBM samples compared to healthy brain samples as well as in glioma-
derived cell lines (Kamino et al., 2011; Pu et al., 2009; Yu et al., 2007), we set 
out to confirm these findings and investigate further. In paper I, we found that 
in a tissue microarray with 48 malignant gliomas and 40 healthy brain samples 
WNT-5A was significantly upregulated in the tumor tissue when analyzed via 
immunohistochemistry. These results were supported by a meta-analysis of the 
TCGA-GBM dataset, showing >4-fold upregulation of WNT-5A in GBM 
samples compared to healthy brain. Despite this, there was no significant 
difference on the median survival of patients showing high WNT-5A mRNA 
levels, pointing towards a more complex effect of WNTs on the pathobiology in 
malignant glioma.  
Nevertheless, we further compared mRNA expression levels of two groups of 
patients, the 25% of patients with highest and lowest WNT-5A expression 
(WNT-5Ahigh vs WNT-5Alow). We found that high WNT-5A levels correlated 
with high expression of genes associated with biological processes linked to 
immunological responses as defined by standard Gene Ontology terminology 
eg. immune response (GO:0006955) and antigen processing and presentation of 
peptide or polysaccharide antigen via MHC class II (GO:0002504) (Figure 2). 
Surprised by the novelty of those results, we performed further in-silico 
analyses using bioinformatics tools such as gene set enrichment analysis 
(GSEA), the Database for Annotation, Visualization and Integrated Discovery 
(DAVID) (Huang et al., 2009a; Huang et al., 2009b), or the software Cytoscape 
in combination with additional plugins such as MiMI or MCode 
(http://allegroviva.com/allegromcode) (Gao et al., 2009; Saito et al., 2012). 
These results also pointed towards a connection between high WNT-5A levels 
and upregulation of genes involved in immune responses and antigen 
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processing. This is in line with the fact that GBMs are known to create local and 
systemic immunosuppression by e.g. regulating cytokine expression in the 
tumor microenvironment thus inducing immune tolerance in the pathologic 
brain (Gomez et al., 2006; Hussain et al., 2006; Komohara et al., 2008; Prosniak 
et al., 2013; Reardon et al., 2014; Szulzewsky et al., 2015; Waziri, 2010).  
 
 
Figure 2. High WNT-5A levels in human GBM correlate with high expression of a 
network of genes linked to immunological processes. (A) MiMI interactome network 
(Michigan Molecular Interactions plugin for Cytoscape) visualizing gene-gene interaction 
networks was defined by determining the differentially expressed genes between the WNT-
5Alow versus WNT-5Ahigh subgroups of the TCGA GBM sample set available at 
https://cancergenome.nih.gov/cancersselected/glioblastomamultiforme. Networks with N≤3 
genes were excluded (B) MCODE analysis of the MiMI interactome network with 
corresponding color coding in (A) finds clusters in a network representing densely connected 
regions. Image from (Dijksterhuis et al., 2015a) 
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Besides a correlative indication for an immune-response signature in the WNT-
5Ahigh group, we also found enrichment of known microglia marker genes 
(Kettenmann et al., 2011) in this patient subgroup. Co-occurrence analysis 
between high WNT-5A and microglia markers confirmed a positive correlation 
between these two, providing hints for the origin of the immune response seen 
on mRNA levels. Furthermore, additional analyses of the TMAs revealed co-
localization of the microglia marker ionized calcium-binding adapter molecule 
1 (IBA-1) and HLA-DMA/HLA-DPB1, two major molecules involved in MHC 
class II antigen processing and response. This co-localization showed 
significant correlation (Pearson coefficient of 0.6144 (p=0.0014) for IBA-
1/HLA-DMA and 0.4458 (p=0.0290) for IBA-1/HLA-DPB1), indicating a 
biologically relevant and statistically significant relationship between HLA 
components and microglia infiltration in the glioma tissue tested. These results 
are in line with the fact that microglia are antigen presenting cells and reports 
pointing to microglia as the source of inflammation in brain tumors and 
neurodegenerative diseases. Subsequent analysis of other MHC class II 
pathway components revealed that several, but not all, important members were 
indeed also enriched in the WNT-5Ahigh group. The fact that not all necessary 
components of the MHC class II pathway were present in the glioma samples 
analyzed is partly in line with reports showing impaired MHC class II antigen 
presentation in cells of the tumor microenvironment and could be one 
mechanism how cancer cells avoid host immune responses (Schartner et al., 
2005). This finding, together with the idea that high levels of microglia 
infiltration into tumor tissues are associated with a poor disease prognosis 
(Kuang et al., 2007; Yang et al., 2010), could to some extent explain the 
aggressiveness and poor prognostic outcome of malignant gliomas. In addition, 
considering studies our group published previously on the effects of WNT-5A 
on microglia migration, invasion, and pro-inflammatory transformation, events, 
which were PTX-sensitive and thus Gαi/o-mediated (Halleskog et al., 2012; 
Kilander et al., 2011a), it is reasonable to assume that most likely some of the 
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WNT-5A-correlative features observed in GBM in paper I might also be 
heterotrimeric G protein-dependent. 
In summary, even though from our data in paper I we cannot directly explain 
the effect WNT-5A exerts on glioma progression, our results point towards a 
novel role of WNT-5A in relation to malignant glioma-associated microglia 
infiltration and possibly also local immunosuppression. Further studies 
outlining more phenotypical details of the tumor microenvironment and 
immunological processes underlying glioma progression are needed to evaluate 
whether elevated microglia presence caused by WNT-5A in these tumors might 
present a valid target for drug development. 
4.2 FZD4-G PROTEIN INTERACTION 
In our quest to dissect WNT/FZD signaling and investigate the mechanisms of 
FZD-G protein interaction, we made use of an established imaging method for 
determining lateral mobility of receptor and G protein after immobilization of a 
distinct receptor fraction and subsequent stimulation of the receptor. This live-
cell imaging approach, FRAP, has been used successfully to study the 
interaction of cytokine receptors and kinases (Giese et al., 2003), interaction 
details of receptors and ion channels (Lober et al., 2006), dissociation of G 
protein subunits (Digby et al., 2006), analysis of receptor oligomerization 
(Dorsch et al., 2009), or inactive-state complex formation of muscarinic 
receptors and heterotrimeric G proteins (Qin et al., 2011). One should mention 
here that when we employ dcFRAP in our studies, we investigate FZD and G 
protein interaction relating to the proposed “preassembly” or “inactive state 
complex” model, similar to what has been described for the M3 receptor using 
the same methodology (Qin et al., 2011). This model for receptor-G protein 
interaction studied here should not be mistaken with the well described 
receptor-G protein coupling, which describes a model for an agonist-activated 
receptor-G protein complex, as was exemplified first with the β2-adrenergic 
receptor in complex with Gαs (Rasmussen et al., 2007).   
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4.2.1 A FZD4-Gα12/13 inactive state complex dissociates upon WNT 
stimulation and assembles independently of DVL 
In paper II, we set out to provide functional evidence strengthening the idea that 
FZDs function as GPCRs (Foord et al., 2005; Kilander et al., 2014b). By using 
a double-color fluorescence recovery after photobleaching (dcFRAP) technique, 
we were able to investigate the inactive-state assembly of receptor and G 
protein in question. FRAP allowed to distinguish whether FZD4 and members of 
the four families of heterotrimeric G proteins are assembled or separated in the 
membrane at any given time. This method is based on immobilization of 
transmembrane proteins by chemical surface crosslinking (CL) with sulfo-
NHS-LC-LC-biotin and avidin. Contrary to transmembrane receptors, 
intracellular proteins, such as heterotrimeric G proteins, are not directly affected 
by surface CL in this assay and their mobile fraction is reduced only upon 
interaction with CL-immobilized surface proteins, such as transmembrane 
receptors. Using this approach in an overexpression system with HEK293 cells, 
we could show for the first time in mammalian cells that FZD4 forms an 
inactive-state complex with Gα12/13 (Figure 3), but not with any of the other 
family members like Gαi/o, Gαs, or Gαq. Adequate controls like using a no-
receptor control or a non-FZD GPCR control allow us to determine with very 
high confidence that the observed decrease in lateral mobility of the G protein 
in question is indeed caused by the formation of an inactive-state assembly with 
the FZD isoform studied. Furthermore, this complex dissociated upon WNT 
stimulation, in the dcFRAP assay, in FRET (Förster resonance energy transfer) 
measurements, as well as indirectly using dynamic mass redistribution (DMR), 
which allows label-free measuring of ligand-induced changes in living cells 
(Grundmann et al., 2015; Schröder et al., 2011).  
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Figure 3. FZD4 and Gα12/13 form an inactive-state assembly complex in HEK293 cells. 
(A) Fluorescently-tagged hFZD4 is expressed primarily in the plasma membrane of 
HEK293 cells. (B) Sketches representing various time points as indicated during the 
dcFRAP analysis. White bars indicate the selected area in the plasma membrane that got 
bleached with high laser intensity. (C-D) Schematic presentation clarifying the 
experimental setup, a confocal micrograph showing HEK293 cells transiently expressing 
FZD4 with the respective Gα subunit, fluorescence intensity curves before (gray) and after 
(red) CL for both FZD4 and the respective G protein and a bar graph summarizing the 
mobile fractions of FZD4 and the Gα subunit under each experimental condition. Color 
code for mobile fractions: white, FZD4 before CL; red hatched, FZD4 after CL; gray, Gα 
before CL; gray + red hatched, Gα after CL. ***p<0.001 (n = 3). Error bars provide the 
S.E.M. ns = not significant.  
Altogether, our data showing the dissociation of the Gα subunits indicate a 
functional FZD4-Gα12/13 complex with the potential to initiate signaling through 
the dissociated G protein subunits. 
In order to further describe this FZD4-Gα12/13 complex and understand how 
signals get relayed from outside the cell to the inside, we took a look at the 
scaffold protein DVL, an important co-factor of the WNT pathway. From 
studies with FZD6 we knew that defined cellular levels of DVL were required 
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for functional assembly of FZD6 with Gαi or Gαq (Kilander et al., 2014b). In 
regards to FZD4-Gα12/13, we determined that DVL was not only dispensable but 
excessive cellular levels also did not disturb the assembly of FZD4 with Gα12/13 
(only increasing exogenous DVL levels to three times the amount commonly 
transfected for this protein prevented complex formation (unpublished data)). 
4.2.2 A WNT-FZD4-Gα12/13-p115-RhoGEF signaling axis 
Heterotrimeric Gα12/13 signal predominantly to the Ras homology gene family, 
member A (RhoA) GTPase and induce downstream signaling effects in cells 
such as changes in cell shape, migration, and adhesion (Worzfeld et al., 2008). 
Gα12/13 signaling to RhoA depends on RhoGTPase guanine nucleotide exchange 
factors (RhoGEFs) such as p115RhoGEF, which interacts with the active, GTP-
bound and from subunits dissociated Gα12/13 (Hart et al., 1998). In paper II, 
we show that FZD4 induces p115RhoGEF recruitment to the plasma membrane 
(Figure 4), strongly arguing for the fact that FZD4 is acting as a guanine 
nucleotide exchange factor (GEF) on heterotrimeric Gα12/13 proteins.  
 
Figure 4. FZD4 induces Gα12/13-mediated p115-RhoGEF 
membrane recruitment, which is dependent on the activation of 
heterotrimeric Gα12/13 proteins. HEK293 cells transiently 
transfected with vectors for FZD4, Gα12 (A) or Gα13 (B), and p115-
RhoGEF either without or with the isolated RGS domain of p115-
RhoGEF-RGS. Cells presenting membranous p115-RhoGEF 
localization were counted manually and data from four independent 
experiments were summarized in the bar graph. Experiment contain 
at least 50 counted cells for each condition and in each independent 
experiment. Values given represent mean ± S.E.M.  
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Since we lack robust pharmacological tools for selectively targeting of FZD 
isoforms, we incubated with the porcupine inhibitor C59 in this assay, which 
has been shown to strongly reduce autocrine WNT secretion (Proffitt et al., 
2013). This had a significant negative impact on the p115RhoGEF recruitment, 
confirming that FZD4-Gα12/13 signaling is WNT-dependent. Complementary to 
this, when we added the p115-RhoGEF RGS domain, which acts as a selective 
GTPase-activating protein (GAP) for Gα12/13 (Hart et al., 1998; Kozasa, 1998) 
and promotes hydrolysis of GTP to GDP thus rendering the G protein inactive, 
we observed a reduction of the FZD4-induced p115RhoGEF recruitment back to 
basal levels (Figure 4). Taken together, these data strongly support for the 
functionality of a WNT-FZD4/Gα12/13-p115-RhoGEF signaling axis with a 
dependence on FZD4-mediated activation of Gα12/13. 
4.2.3 Norrin signaling through a FZD4-Gα12/13 signaling axis  
In paper III, which is currently in manuscript form, we built on the findings 
from paper II, namely that FZD4 forms an inactive-state complex with and 
activates Gα12/13 and take them one step further. We show that the FZD4-
selective and WNT-unrelated protein ligand Norrin, which is considered a 
selective agonist for the FZD4-LRP5/6 receptor complex, can also activate 
FZD4-G protein signaling along the Gα12/13 axis but independent of LRP5/6. 
These novel findings add to the complexity of the FZD-ligand repertoire and 
largely unknown selectivity, as Norrin has thus far only ever been reported to 
interact with FZD4 together with the co-receptor LRP5/6 to activate WNT/-
catenin signaling in mammalian cells (Xu et al., 2004). Furthermore, we shed 
light on the interaction between the historically separated and generally termed 
β-catenin-dependent and β-catenin-independent WNT signaling pathways in 
regards to FZD4 and thus offer hints that these pathways most likely share 
common elements or converge at various points to either potentiate or inhibit 
signaling outcomes.  
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Based on our previous findings of a FZD4-Gα12/13 signaling axis, we set out to 
test the non-WNT ligand Norrin and its ability to dissociate this receptor-G 
protein complex. In line with results we observed previously when stimulating 
with WNTs (paper II), the FZD4-Gα12/13 inactive-state complex dissociated upon 
Norrin stimulation in a dcFRAP setup in HEK293 cells, pinpointing to an active 
ligand-receptor-G protein complex. Because Norrin has in the past repeatedly 
been associated with FZD4 and LRP5/6 (Junge et al., 2009; Xu et al., 2004), we 
investigated the importance of these FZD co-receptors by overexpressing a 
dominant negative and phosphorylation-deficient LRP6-AAAAA construct 
(Wolf et al., 2008). However, we did not observe any changes in the dcFRAP 
assay showing the formation of a FZD4-Gα12/13 complex in the presence of the 
dominant negative LRP6 construct. Furthermore, to verify the functionality of 
this complex and its independence of endogenous LRP5/6 we pre-incubated 
with the selective LRP5/6 inhibitor DKK-1, which interferes with LRP5/6 
involvement, before stimulating with Norrin. Despite blocking LRP5/6, Norrin 
still caused dissociation of Gα12 from FZD4. These data suggest that Norrin is 
capable of activating FZD4 without recruitment of LRP5/6. This is particularly 
interesting for two reasons: one, in light of previous reports of Norrin and FZD4 
claiming LRP5/6 as a crucial cofactor in this complex to initiate β-catenin-
dependent signaling (Junge et al., 2009; Xu et al., 2004; Ye et al., 2009); two, 
underlying mutations for diseases such as familial exudative vitreoretinopathy 
(FEVR), an inherited blinding disorder of the retinal vascular system (Criswick 
et al., 1969), have initially been found in FZD4 and Norrin, but later also in 
LRP5/6 (Chen et al., 1993; Jiao et al., 2004; Robitaille et al., 2002; Toomes et 
al., 2004).  
To further investigate the activated signaling paths downstream of FZD4 and 
Gα12/13, we focused on recent reports claiming a connection between Gα12/13 
signaling and RHO activation feeding into YAP/TAZ signaling (Hot et al., 
2017; Park et al., 2015; Schlessinger et al., 2009; Yu et al., 2012; Zhao et al., 
4   Results & Discussion 
 35 
2012). To explore this hypothesis, we tested the synthetic 8xGTIIC luciferase 
reporter assay to monitor transcriptional activation downstream of the 
transcriptional regulators YAP and TAZ (Dupont et al., 2011). Overexpressing 
FZD4 in HEK293 cells provoked a stable induction of the YAP/TAZ luciferase 
reporter, which was absent in HEK293 cells lacking both Gα12 and Gα13. 
Further, adding the Gα12/13-selective regulator of G protein signaling (RGS) 
domain of p115RhoGEF, which functions as a GTPase-activating protein 
(GAP), completely abrogated both basal and FZD4-induced YAP/TAZ 
activation in parental cells, but had little effect in Gα12/13 KO cells. This 
confirms that the FZD4-induced activation of YAP/TAZ is dependent on 
Gα12/13. Based on the surprising findings that LRP5/6 was irrelevant for 
formation and dissociation of a FZD4-Gα12/13 inactive-state complex in HEK293 
cells, we tested the role of LRP5/6 in regards to YAP/TAZ activation. When 
using the 8xGTIIC luciferase reporter in LRP5/6 deficient and corresponding 
parental HEK293 cells, FZD4 expression induced stable YAP/TAZ-dependent 
transcriptional activity in parental cells and significantly higher activity in 
LRP5/6 deficient cells. These results corroborate the idea that a FZD4-Gα12/13-
YAP/TAZ signaling route does not require LRP5/6, and might even be partly 
inhibited by it, and thus constitutes a parallel signaling path to the well-known 
Norrin-FZD4-LRP5/6 signaling axis described above. 
Stunned by the novel observation that FZD4 has the potential to activate a 
Gα12/13–mediated and YAP/TAZ-dependent signaling path, we wanted to know 
whether this Gα12/13-dependent FZD4 signaling axis might interfere with the 
known FZD4-LRP5/6-β-catenin signaling route. To do this, we tested the β-
catenin TOPFLash luciferase reporter in Gα12/13 KO and corresponding parental 
cells in combination with FZD4, Norrin, and LRP5/6. Surprisingly, the 
TOPFlash signal induced by FZD4-Norrin-LRP5 or FZD4-Norrin-LRP6 
increased in the Gα12/13 KO cells. This increase was partially reversed by 
expressing ectopic Gα12 or Gα13 proteins. Furthermore, expression of the RGS 
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domain of p115RhoGEF, which promotes GTP hydrolysis and thus inactivation 
of the G protein, enhanced the TOPFlash response in parental cells in 
combination with FZD4-Norrin-LRP6. All things considered, the results 
strongly point towards active FZD4-Gα12/13 signaling as a negative regulator of 
FZD4-β-catenin signaling. Based on our results obtained, we provide new 
evidence for a central role of Gα12/13 in FZD4-mediated signaling to β-catenin as 
well as β-catenin-independent downstream targets.  
 
 
Figure 5. Gα12/13 regulates a Norrin-FZD4 signaling loop. 
Schematic cartoon of a proposed Norrin-FZD4 signaling loop 
regulated by Gα12/13. On one hand, Norrin binding to FZD4, 
together with LRP5/6, activates β-catenin and TCF/LEF-
mediated transcriptional regulation. On the other hand, Norrin 
binding to FZD4 causes a dissociation of Gα12/13 and induces 
YAP/TAZ-mediated transcriptional regulation sensitive to 
blockage through the RGS-domain of p115RhoGEF. The 
crosstalk level and details of the negative feedback of Gα12/13 
signaling towards the FZD4-Norrin-LRP5/6-β-catenin axis 
remain vague.  
On one hand, we show that Norrin can act as a FZD4 agonist to induce LRP5/6-
independent signaling. Regarding physiological functions involving FZD4, this 
could mean that endothelial cell physiology in angiogenesis might not only 
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depend on the known FZD-LRP5/6-β-catenin signaling axis but also on a novel 
FZD4-Gα12/13 signaling route. Such a concept would be in line with findings 
suggesting a crucial role for Gα12/13 in angiogenesis (Offermanns et al., 1997; 
Sivaraj et al., 2013). On the other hand, we provide hints for a concept that 
states that the FZD4-β-catenin pathway involving LRP5/6 might ultimately be 
controlled and regulated by FZD4-G protein signaling. Since both signaling 
routes seem to be present and activated in parallel, G protein-mediated 
inhibition could play an important role in FZD4 signal compartmentation and 
bidirectional pathway regulation (Figure 5). Taken together, besides the known 
role of FZD4 in -catenin-dependent signaling (Junge et al., 2009; Xu et al., 
2004; Ye et al., 2009), our evidence strongly suggests a -catenin-independent 
role of FZD4-Gα12/13, not just in combination with Norrin (paper III) but also 
WNT stimulation (paper II).  
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5 GENERAL DISCUSSION & PROSPECTIVE OUTLOOK 
WNT/FZD signaling has been studied extensively for over three decades and 
remains one of the most enigmatic distinct signaling pathways known in 
biology. Class Frizzled receptors share several typical features of classical 
GPCRs, yet detailed mechanistic descriptions are rare for the mere endless pool 
of signaling combinations of WNT-FZD-G protein and other co-factors in this 
pathway. In this thesis, I aimed to give insights into WNT/FZD pharmacology 
from various aspects, starting from biology and pathophysiology in regards to 
WNT-5A to signaling mechanistics of FZD4. In the various studies discussed 
herein, we attempted to dissect the details lacking in the current understanding 
of WNT/FZD signaling cascades, from ligand binding to receptor and G protein 
involvement and activation to downstream signaling specification and signaling 
initiation resulting in cellular changes and potential feedback loops. This thesis 
provides novel elements on the previously unappreciated depth and complexity 
of WNT/FZD signaling and by no means intends to provide a complete story 
but rather to serve as the basis for further studies and for the development of 
more sophisticated tools and techniques to study WNT/FZD signaling in 
unprecedented detail. 
Some of the results reported in this thesis raise various interesting questions 
providing grounds for discussions and further research (and more sophisticated 
methodological tools), some of which I would like to briefly address here. 
Generally, studying WNT/FZD pharmacology is cumbersome due to several 
factors:  
i. Receptor-ligand complexity:  
Enormous diversity of WNT signal activation exists due to the presence 
of 19 WNTs and 10 FZDs in mammals, as well as several co-receptors. 
When looking at research from our group and many others in the field, it 
has become more and more obvious that various FZDs can respond to the 
same WNT isoform in many of the conventional cell lines studied, and 
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most certainly also in the living organism. Therefore, precise receptor 
profiles and expression levels of the cell system in question are necessary 
in order to define a specific WNT-FZD target signaling route.  
ii. Ligand intricacy: 
WNT proteins are secreted molecules influencing and orchestrating a 
myriad of cellular processes. Due to the addition of lipid adducts during 
posttranslational modifications, WNTs are highly hydrophobic and tend 
to “stick” to a multitude of carrier molecules or the plasma membrane. 
Therefore, it is difficult to determine a physiological effective 
concentration of WNTs. In addition, due to the intrinsic instability of 
WNTs, knowing the exact concentration of a given recombinant WNT 
product is near impossible. Therefore, important pharmacologically terms 
such as efficacy, affinity, and potency are difficult to assess when dealing 
with recombinant WNTs.  
iii. Class Frizzled receptors as unconventional GPCRs 
Despite sharing several structural features of classical GPCRs, it remains 
a challenge to study FZD-G protein interaction, and so far, no attempt to 
obtaining a crystal structure of a FZD has been successful. Based on 
reports and studies performed in this thesis, it has become clear that 
FZDs can act as both classical and non-classical GPCRs, signaling via 
heterotrimeric G proteins or without the help thereof. These mechanistic 
subtleties may likely depend on the cell type or tissue in question and 
their repertoire at of endogenous WNTs, FZDs, and co-factors at any 
given time.  
Considering the above-mentioned difficulties, it is obvious that classical tools 
for studying GPCR activation are most likely bound to fail. It cannot be 
emphasized enough, that studying WNT/FZD/G protein signaling pathways 
requires the use and development of alternative and sophisticated approaches, 
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likely with the need to tailor them based on the cell type or experimental model 
used. A start to this would be the much-needed development of isoform-
selective small-molecule inhibitors for FZDs.  
In the first part of this thesis, we tried to elucidate the presence and role of 
WNT-5A in GBM. WNT-5A has for quite some time been linked to cancer, but 
astonishingly, this WNT protein is capable of acting in an oncogenic as well as 
tumor-suppressing manner, depending on the cancer type (view (Asem et al., 
2016) for a comprehensive and up-to-date review). Based on previous studies 
by our group and others, we knew that microglia play an important role in the 
immunological protection of the brain but also in GBM progression (Yang et 
al., 2010). At the same time, WNT-5A exerts proliferative effects on microglia 
(Kilander et al., 2011a), which are G protein-dependent, and can cause pro-
inflammatory cytokine release (Halleskog et al., 2012) and increase migration 
and invasion of microglia (Halleskog et al., 2012). Several studies showing 
microglia are a major component of the glioma microenvironment as well as 
our findings on the effect of WNT-5A led us to investigate this WNT in GBM. 
As discussed for paper I, the involvement of WNT-5A in the overall GBM 
disease progression is not entirely clear. We can conclude that high WNT-5A 
mRNA levels result in high protein levels in the tumor microenvironment of 
GBM patients. In addition, in these WNT-5Ahigh patients increased numbers of 
microglia are found, yet no correlative effect on the overall survival was found. 
This raises doubts whether targeting WNT-5A pharmacologically in these 
patients might add any additional benefits. The second highlight of paper I, 
namely the finding that WNT-5Ahigh patients showed an increase in MHC Class 
II components, might present as a more attractive target. Targeting the 
increased number of microglia in the tumor microenvironment, or manipulating 
the tumor and its environment to express all necessary factors for functional 
MHC Class II antigen presentation might provide one option, yet certainly not a 
cure, for the devastating prognosis of this disease.  
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In the second part of this thesis, we aimed to more closely investigate the 
signaling specifics of the WNT receptor FZD4. Even though this receptor has 
repeatedly been implicated in physiological processes, all mostly relating to 
angiogenesis (Robitaille et al., 2002; Xu et al., 2004; Ye et al., 2009) as well as 
some cancers (Acevedo et al., 2007; Planutis et al., 2007), few mechanistic 
details are known about FZD4-specific signaling pathways. In paper II, we shed 
light into a major “black box” regarding FZD4 signaling by defining the family 
of heterotrimeric G proteins this receptor binds to and interacts with, as Gα12/13. 
With the help of a recently developed and successfully used approach to 
determine GPCR-G protein complex formation, double color FRAP (Dorsch et 
al., 2009; Giese et al., 2003; Qin et al., 2011), we could so far define G protein 
interactions for FZD4 (Arthofer et al., 2016), FZD6 (Kilander et al., 2014b), and 
FZD10 (Hot et al., 2017). Regarding the interaction of FZD4 with Gα12/13, these 
results might not come as a complete surprise considering that studies in the 
past described a crucial role for Gα12/13 in angiogenesis (Offermanns et al., 
1997; Sivaraj et al., 2013), aligning with the proposed physiological roles 
observed for FZD4 in angiogenesis (Junge et al., 2009; Xu et al., 2004; Ye et al., 
2009). Despite the almost obvious overlaps, no other studies so far have 
suggested a functional interaction between FZD4 and Gα12/13. In paper III, we 
further deepened our focus on the non-WNT and FZD4-selective ligand Norrin. 
Building on the newly discovered connection between FZD4 and Gα12/13 as well 
as known reports of a Norrin-FZD4-LRP5/6 signaling route towards β-catenin-
mediated signaling, we established the existence of a Norrin-FZD4-Gα12/13 
signaling axis, independent of LRP5/6 (and unfortunately thus yet another 
WNT/FZD signaling cascade). Further experiments revealed what recent 
reports have been suggesting too, which is that distinct FZD signaling paths, or 
simply β-catenin-dependent and β-catenin-independent pathways, might 
interact, share common features, or even potentiate or inhibit each other’s 
signaling outcomes. It would add tremendous amount of knowledge to the field 
if detailed concepts of how one distinct FZD signaling route affects or interacts 
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with another distinct FZD signaling path. For reasons discussed above in i-iii as 
well as time and methodological limitations, more in-depth studies on these 
cross-pathway signaling relationships were not within the scope of this thesis. 
In summary, the results presented and discussed in this thesis contribute to the 
understanding of WNT/FZD pharmacology and signaling. We aimed at 
investigating the WNT/FZD signaling pathway at different levels, ranging from 
basic pharmacological and biochemical properties to pathobiological relevance 
in brain tumors. The overall goal of our work is to improve the understanding of 
this important family of signal transduction pathways to accelerate the 
development of therapeutic approaches targeting this pathway in the future. 
 
 
 
Ultimately, the objective of performing basic research is the idea to understand 
how the human body works and how to intervene when processes go wrong. 
This is, as many researchers know, much easier said than done. The majority of 
findings coming from basic research are likely to never get “translated” into any 
form of clinical use. Even research findings, which do end up going through 
some or all of the several stages of (pre)-clinical development, it is not ensured 
they will result in a medicinal product or medical device ultimately aiming to 
improving human health and wellbeing. In order to improve this, I am 
proposing several approaches for the future: modern concepts for biomedical 
research facilities should incorporate the idea of translational science being an 
integral part already at the level where basic science is performed. Second, 
improved and regular communication and scientific exchange between 
scientists of various areas, whether this might be basic sciences, applied 
sciences, high-throughput screenings and drug discovery, or in vivo research, 
should be of utmost importance to everyone involved in performing research in 
these areas. Incorporating broad knowledge and research findings from all these 
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disciplines, continuously and at an early stage in research, will be extremely 
beneficial for the advancement of biomedical research.  
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6 SUMMARY 
Paper I 
- WNT-5A protein levels are upregulated in human glioma tissue 
compared to non-malignant control brain tissue.  
- WNT-5A is the only representative of the WNT ligand family 
upregulated on mRNA levels in human glioma samples compared to non-
malignant control brain samples. 
- High WNT-5A expression levels in gliomas are associated with 
upregulation of immune-related and pro-inflammatory factors. 
- High levels of WNT-5A expression in gliomas correlate with a 
significant increase of HLA gene family-positive microglia/monocytes. 
- Based on previously published in vitro data, the effects of WNT-5A on 
glioma-associated microglia could at least in part be G protein-
dependent. 
 
Paper II 
- FZD4 assembles with Gα12 and Gα13 to form an inactive-state complex in 
mammalian cells. 
- The FZD4-Gα12/13 complex dissociates upon WNT stimulation as 
observed by dcFRAP, FRET, and indirectly also by DMR measurements. 
- The WNT scaffold protein DVL is dispensable for FZD4-Gα12/13 complex 
formation. 
- DMR measurements show that WNT-induced changes are Gα12/13-
dependent, in HEK293 cells overexpressing FZD4 as well as at 
endogenous levels. 
- FZD4-Gα12/13 mediate RHO signaling through membrane recruitment of 
p115-RhoGEF. 
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Paper III 
- FZD4-Gα12/13 complex formation does neither depend on the functionality 
nor activation of LRP5/6. 
- Norrin stimulation dissociates and activates a FZD4-Gα12/13 inactive state 
complex, independent of LRP5/6, pointing towards a previously 
unknown and β-catenin-independent Norrin-FZD4-Gα12/13 signaling route. 
- FZD4 mediates YAP/TAZ signaling in a Gα12/13-dependent manner and 
independently of LRP5/6, thus representing a parallel signaling path to 
the recognized Norrin-FZD4-LRP5/6 signaling axis. 
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